
About Insud Pharma
Insud Pharma is a Healthcare company based in Madrid (Spain) founded in 1977 by Hugo Sigman and Silvia Gold. Finished formulations, APIs, and monoclonal antibodies are developed and manufactured. It operates on a Direct-to-Consumer (D2C) model. Insud Pharma has completed 2 acquisitions, including Agile Therapeutics and Viatris. Its website insudpharma.com draws about 15 thousand monthly visits. Insud Pharma offers products and services including Pharmaceutical Solutions. Its focus areas include Pharmaceuticals and Drug Manufacturing. Its legal entity is Insud Pharma, S.L.
Company details
Insud Pharma is involved in the development and manufacturing of pharmaceutical solutions aimed at improving global health. The company operates across various sectors within healthcare, focusing on innovative drug production. With a presence in over 50 countries, numerous industrial plants, and RD centers, comprehensive health solutions are provided to meet diverse needs. Sustainability and ethical practices are integrated into operations to ensure responsible growth.
- Headquarters Madrid, Spain
- Founders Hugo Sigman, Silvia Gold
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website insudpharma.com
- Social LinkedIn X Instagram
- Legal Name Insud Pharma, S.L.
- Latest Funding Round$2.7M (USD), Grant
Nov 2024
- Investors
- Investments & AcquisitionsAgile Therapeutics
& 1 more
Products & Services of Insud Pharma
Insud Pharma offers a comprehensive portfolio of products and services, including Pharmaceutical Solutions.
Pharmaceutical solutions are developed for global health needs.
Funding Insights of Insud Pharma
- Total Rounds 1
- Last Round Grant β $2.7M
- First Round $2.7M
(Nov 2024)
- Investors Count 1
All 1 funding rounds of Insud Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2024 | $2.7M | Grant | β | β |
1 investors in total: 1 institutional.
Investors in Insud Pharma
Insud Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Gates Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Charitable foundation investments on poverty reduction and healthcare | 2000 | gatesfoundation.org | Seattle, United States |
Investor details for Insud Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Insud Pharma
34 people are tracked at Insud Pharma (14 in leadership, 20 in team).
| Name | Role | Group |
|---|---|---|
Hugo Sigman | Co-Founder | Leadership |
Silvia Gold | Co-Founder | Leadership |
Lucas Sigman | CEO | Leadership |
Baburao Walunj | Head Of Quality Control | Leadership |
Mirian Cuenca | Global Regulatory Affairs Director | Leadership |
Ariel Plaza | Director Corporativo Global De EHS | Leadership |
Rajesh Aher | Head Of Department EHS | Leadership |
Carlos Romero-Camacho | Chief People & Corporate Affairs Officer | Leadership |
Ed Carey | VP & Global Head, Quality & Compliance | Leadership |
Jørgen Matz | Head, Global Clinical Quality & Pharmacovigilance | Leadership |
Nihal Hamdalla | Director Of Supply, Regulatory, Quality, Pv. MEA Region | Leadership |
Zuleyha Aygun | Quality Systems & Compliance Director | Leadership |
Antonella Volpe | Global API Quality And Regulatory Director | Leadership |
Emilio J. Pericet Grande | Chief Technology Officer | Leadership |
Vasu Morla | Agm, Global CQA | Team |
Isabel Perdiguero Osuna | Quality Assurance Supervisor | Team |
Erica Heringer | Project And Quality Manager | Team |
Carmen Cortina | Patient Safety Physician And Risk Mitigation Manager | Team |
Lucía López Castro | Regulatory And Quality API Technician | Team |
Cecilia Morán Seijas | Quality Assurance Supervisor, Validations - Deputy QP | Team |
14 more people are available in the full profile.
Complete people profiles for Insud Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Insud Pharma
Insud Pharma has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Agile Therapeutics and Viatris.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Therapeutics for women's healthcare are developed and offered. | agiletherapeutics.com | Princeton, United States | 1997 | Aug 2024 | β’β’β’β’ | |
Branded pharmaceuticals are developed and commercialized by Viatris internationally. | viatris.com | Frankfurt, Germany | 1998 | Mar 2024 | β’β’β’β’ |
Complete acquisition details for Insud Pharma
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Insud Pharma
4 dated milestones of Insud Pharma across 47 years, from founding to its latest funding, stage changes and deals.
- Founded Insud Pharma is founded.
- Acquisition Acquires Viatris.
- Acquisition Acquires Agile Therapeutics.
- Funding First funding round of $2.7M.
Web traffic of Insud Pharma
The website of Insud Pharma (insudpharma.com) receives about 14.6K visits a month and ranks #1,472,055 among all websites worldwide, #1,928 in Biotechnology and Pharmaceuticals.
- Monthly visits14.6K
▼ 5.9% vs previous month
- Unique visitors6.8K
per month
- Global rank#1,472,055
among all websites
- Category rank#1,928
Health · Biotechnology and Pharmaceuticals
- Bounce rate36%
- Pages per visit2.3
- Average visit57 sec
- DevicesDesktop 47% Β· Mobile 53%
Websites whose visitors overlap most with Insud Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| concordbiotech.com | 100% | 3.7K | #4,215,278 | View details | |
| swisspharma.in | 96% | 1.3K | #10,147,211 | View details | |
| alembicpharmaceuticals.com | 90% | 23K | #2,083,600 | View details | |
| nilrisepharma.com | 88% | #3,419,796 | View details | ||
| cadilapharma.com | 87% | 18.5K | #1,452,788 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 13 similar websites and full traffic analytics for Insud Pharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 13 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Insud Pharma
Complete news archive for Insud Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Insud Pharma
Insud Pharma was founded in 1977 and raised its 1st funding round 47 years after it was founded.
Insud Pharma is headquartered in Madrid, Spain. It is registered at Madrid, Madrid, Spain.
Insud Pharma is involved in the development and manufacturing of pharmaceutical solutions aimed at improving global health. The company operates across various sectors within healthcare, focusing on innovative drug production. With a presence in over 50 countries, numerous industrial plants, and RD centers, comprehensive health solutions are provided to meet diverse needs. Sustainability and ethical practices are integrated into operations to ensure responsible growth.
Insud Pharma offers Pharmaceutical Solutions.
Insud Pharma has made 2 acquisitions, including Agile Therapeutics, and Viatris.
Insud Pharma has 1 investor. Key investors include Gates Foundation.
Insud Pharma operates through Insud Pharma, S.L..
